These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6494054)

  • 21. Detrimental effect of steroids on cyclosporin-A-induced prolonged allograft survival.
    Dunn DC; White DJ; Herbertson BM; Rolles K
    Transplant Proc; 1980 Jun; 12(2):335-8. PubMed ID: 6994303
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclosporin A: a new immune suppressive agent.
    Sheil AG
    Med J Aust; 1982 Jan; 1(1):37-9. PubMed ID: 7038415
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased efficacy of cyclosporin A with splenectomy prolonging the survival of rat heart allografts.
    Downing TP; Reitz BA; Stinson EB; Aziz S; Shumway N
    Transplantation; 1981 Jul; 32(1):76-7. PubMed ID: 7022803
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cyclosporin A--a new immunosuppressant].
    Robak T
    Pol Arch Med Wewn; 1984 Feb; 71(2):127-34. PubMed ID: 6377252
    [No Abstract]   [Full Text] [Related]  

  • 25. Preferential efficacy of cyclosporin?
    Lancet; 1985 Mar; 1(8431):755. PubMed ID: 2858022
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cyclosporin, a new immunosuppressive agent?].
    Häyry P
    Duodecim; 1984; 100(13):768-76. PubMed ID: 6386430
    [No Abstract]   [Full Text] [Related]  

  • 27. Properties of cyclosporin--A-induced graft acceptance.
    White DJ; Timmerman W; Davies HS; Nagao T; Kasahara K; Plumb A
    Transplant Proc; 1981 Mar; 13(1 Pt 1):379-82. PubMed ID: 7022857
    [No Abstract]   [Full Text] [Related]  

  • 28. Meshed allograft skin and cyclosporin immunosuppression.
    Towpik E
    Br J Plast Surg; 1989 Sep; 42(5):618. PubMed ID: 2804538
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclosporin A: a powerful immunosuppressant.
    Laupacis A; Keown PA; Ulan RA; McKenzie N; Stiller CR
    Can Med Assoc J; 1982 May; 126(9):1041-6. PubMed ID: 7074504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orthotopic heart and combined heart and lung transplantation with cyclosporin-A immune suppression.
    Reitz BA; Bieber CP; Raney AA; Pennock JL; Jamieson SW; Oyer PE; Stinson EB
    Transplant Proc; 1981 Mar; 13(1 Pt 1):393-6. PubMed ID: 6791329
    [No Abstract]   [Full Text] [Related]  

  • 31. The side effects of cyclosporin A: clinical and histologic findings following 31 canine heterotopic cardiac allotransplants.
    Painvin GA; Heimbecker RO; Keown PA; Stiller CR; Silver MD; McKenzie N
    Curr Surg; 1983; 40(2):120-2. PubMed ID: 6342978
    [No Abstract]   [Full Text] [Related]  

  • 32. The interaction of cyclosporin A with other immunosuppressive agents in dog recipients of renal allografts.
    Homan WP; French ME; Fabre JW; Millard PR; Denton TG; Morris PJ
    Transplant Proc; 1980 Jun; 12(2):287-90. PubMed ID: 6994297
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of local administration of cyclosporin A on corneal graft survival in the rabbit].
    Kana JS; Hoffmann F; Buchen R; Krolik A; Wiederholt M
    Fortschr Ophthalmol; 1982; 79(2):132-4. PubMed ID: 6764207
    [No Abstract]   [Full Text] [Related]  

  • 34. Cadaveric renal transplantation in patients over 55 years of age with special emphasis on immunosuppressive therapy.
    Lundgren G; Fehrman I; Gunnarsson R; Lindholm B; Tillegård A; Ost L; Groth CG
    Transplant Proc; 1982 Sep; 14(3):601-4. PubMed ID: 6758244
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiac allograft survival in cynomolgus monkeys treated with cyclosporin-A in combination with conventional immune suppression.
    Pennock JL; Reitz BA; Bieber CP; Jamieson SW; Raney AA; Oyer PE; Stinson EB
    Transplant Proc; 1981 Mar; 13(1 Pt 1):390-2. PubMed ID: 7022859
    [No Abstract]   [Full Text] [Related]  

  • 36. [Possibilities of immunosuppressive therapy in reconstructive keratoplasty (experience gained in the use of cyclosporin)].
    Kasparov AA; Aladinskaia IV
    Vestn Oftalmol; 2002; 118(4):16-8. PubMed ID: 12371314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long term survival of allografted muscle precursor cells following a limited period of treatment with cyclosporin A.
    Watt DJ; Morgan JE; Partridge TA
    Clin Exp Immunol; 1984 Feb; 55(2):419-26. PubMed ID: 6697568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serious interaction between cyclosporin A and sulphadimidine.
    Jones DK; Hakim M; Wallwork J; Higenbottam TW; White DJ
    Br Med J (Clin Res Ed); 1986 Mar; 292(6522):728-9. PubMed ID: 3082414
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunosuppression by Cyclosporin A in human renal transplant recipients.
    Ringdén O; Bergstrand A; Collste H; Grimfors G; Lundgren G; Groth CG
    Scand J Urol Nephrol Suppl; 1981; 64():220-9. PubMed ID: 6755683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure and function of small bowel allografts in the dog: immunosuppression with cyclosporin A.
    Reznick RK; Craddock GN; Langer B; Gilas T; Cullen JB
    Can J Surg; 1982 Jan; 25(1):51-5. PubMed ID: 7055764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.